TAK-853

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-853, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors [Phase 1, Phase 2]

See pricing